INTRODUCTION
The origin of cholesterol accumulation within the arterial intima has been the subject of numerous investigations. Previous studies have indicated that
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Received for publication 15 May 1967 and in revised form 26 October 1967. plasma cholesterol is an important source of arterial cholesterol (2) (3) (4) , but the role of local intimal synthesis of cholesterol in its accumulation has not been clearly defined. Siperstein, Chaikoff, and Chernick demonstrated cholesterol synthesis in isolated rabbit and chicken aorta (5) and similar results were noted in calf and swine arteries by Werthessen, Milch, Redmond, Smith, and Smith (6) and in rat aorta by Dady, Deming, Raeff, and Brun (7) . However, the studies of Azarnoff with human arteries have suggested that human intimal cholesterol synthesis does not occur (8) .
The present investigation was designed to reexamine the question of arterial sterol synthesis in isolated segments of human arteries. In addition, the body conversion of cholesterol to other sterols and the deposition of these sterols in the intima has been studied in terminally ill patients receiving labeled cholesterol. Multiple chromatographic techniques were utilized in a complementary manner for the isolation and identification of intimal sterols. The results indicate that the human arterial intima has -the capacity to incorporate labeled acetate and mevalonate into both cholestanol (dihydrocholesterol) and cholesterol with the major incorporation present into the cholestanol fraction. The studies also indicate that conversion of cholesterol to cholestanol in the body can occur, and that exchange of cholestanol between the blood and tissues takes place.
METHODS
Human arteries which were removed at surgery (Patients 1-3, 5, and 7) or at postmortem examination within 4 hr of death (Patients 4, 6, and 8) were prepared for incubation as previously described (9) . The tissues were suspended in 10 ml of incubation solution (9) containing The Journal of Clinical Investigation Volume 47 1968 either acetate-1-"4C (1.0 /Lc/ml, SA, 53.0 mc/mmole),' or mevalonate-2-uC (0.5 /hc/ml, SA, 1.22 mc/mmole).1
Incubations were carried out for 6 hr at 370C in a Dubnoff shaker in an atmosphere of 95% 02-5% CO2. The total amount of incubated tissue ranged from 0.5 to 3.0 g with 0.3 to 0.5 g in each incubation flask. The studies were carried out under sterile conditions and cultures of the incubation solution at the termination of study revealed no growth of microorganisms. Atherosclerosis was graded by visual inspection (4) .
After incubation, the tissues were washed five times, blotted, minced, and homogenized in chloroform-methanol 2: 1 (v/v). Aliquots of the minced tissue were dried to a constant weight and the result expressed in terms of dry tissue weight. The tissue lipids were extracted by the method of Folch, Lees, and Sloane Stanley (10) . Aliquots of the lipid extract were saponified with KOH and the sterols precipitated with digitonin (4). The sterol content and radioactivity of the digitonin precipitate were measured as previously described (4) .
Thin-layer chromatography (TLC) system 1. The chloroform-methanol tissue extract was transferred to pointed tubes and reduced to a smaller volume under a stream of nitrogen. The intimal lipids were separated into lipid groups by TLC on silica gel G2 (11) . The plates were exposed to iodine vapors and the individual spots circled and identified by comparison with standards of lecithins cholesterol,4 oleic acid,5 tripalmitin,6 cholesteryl oleate,4 and squalene.3 The sterol and sterol esters were scraped from the plates and extracted at 60'C in centrifuge tubes with 3 X 10 ml of benzene. The cholesterol ester fraction (also containing squalene) was saponified with KOH and an aliquot was re-run on TLC using the same system. The free sterols were combined and the total sterol content and radioactivity determined.
TLC system 2. The major portion of the extract from TLC system 1 was again reduced to a small volume and the 27-carbon (C-27) sterols were isolated by TLC on silica gel G prestained with Rhodamine 6 G 7 according to the method of Avigan, Goodman, and Steinberg (12) . The sterols were eluted as described above and the sterol content and radioactivity measured. The addition of unlabeled lanosterol4 or ergosterol4 to the extract as carriers before chromatography did not affect the distribution of sterol radioactivity on the chromatoplates. The recovery of both cholesterol and cholestanol standards from the silica gel after chromatography and elution averaged 98% (range 97-101%). Cholestanol was quantitated in the recovery experiments by the anthrone color reaction (13).
TLC system 3. Aliquots of the eluate from TLC system 2 were analyzed by TLC to separate cholesterol, cholestanol, and 7-dehydrocholesterol (A 5, 7 cholestadienol) using silica gel G presprayed with 25% Ag NOs (14) . The samples were run with and without carrier cholestanol and 7-dehydrocholesterol. The plates were sprayed with distilled H20 and the sterols identified by comparison with known standards. The sterols were extracted with 50% ethanolic ammonia and benzene (14) and the radioactivity assayed. The recovery of cholesterol and cholestanol after chromatography and elution averaged 78 and 74%, respectively. TLC system 4. To isolate lathosterol (A7-cholestenol from cholestanol and cholesterol, portions of the extracts from TLC system 3 were analyzed on silica gel G using 40 cm glass plates and benzene-ethyl acetate 20: 1 as described by Avigan et al. (12) . Carrier lathosterol 6 was added before chromatography. The sterols were extracted with benzene and their radioactivities assayed.
TLC system 5. TLC of squalene was performed on silica gel G on aliquots of the eluate from TLC system 1 that contained squalene, according to the method of Goodman (15) . Carrier squalene was added before chromatography. The squalene band was isolated and the radioactivity determined as described (9) .
Column chromatography. Aliquots of the extract from TLC system 2 were analyzed by silicic acid-super-cel chromatography as described by Frantz (16) . Fractions of 5 ml each were collected from the column and color was developed in representative aliquots by the Liebermann-Burchard reaction after 1.5 and 30 min. All the sterol present was of the slow reacting type. A peak with an R, value equal to cholesterol represented from 98.8 to 99.7% of the total sterols applied to the column with the remainder appearing in the chromatographic fraction with Rt value similar to desmosterol. Cholesterol was not resolved from cholestanol or 7-dehydrocholesterol by this technique. The fractions were recombined into groups corresponding to the chromatographic behavior of the different sterols and the sterol radioactivity was determined. The recovery of both cholesterol and cholestanol averaged 97%.
Gas-liquid chromatography (GLC). Portions of the eluate from TLC system 2 were analyzed by GLC on methyl silicone gum (General Electric) (SE-30) and methyl fluoroalkyl silicone (QF-1) packed columns 8 with a Model 400 Series chromatograph equipped with an effluent splitter. With SE-30, the retention times of cholesterol and cholestanol were virtually identical but on QF-1, the retention time of cholestanol was 1.1 times that of cholesterol. After injection the compounds represented by each peak on the chromatographic tracing and also the intervening areas were collected individually on Teflon tubes at the GLC outflow portal. The material was extracted from the tubes with 5 X 5 ml of warm benzene and then assayed for "4C-radioactivity.
Approximately 50-100 ,ug of sterol was applied to the column with each injection. The recovery of sterol after chromatography and elution averaged 27%.
Purification of cholesterol by dibromide formation.
Aliquots of the eluate from TLC system 2 were purified by dibromide formation according to the method of Schwenk and Werthessen (17) and the cholesterol specific activity assayed. The recovery of cholesterol averaged 65%. Purification of cholestanol by oxidation. The cholestanol-containing fraction from TLC system 3 in Patient 8 was also treated with formic acid and hydrogen peroxide after addition of 50 mg cholestanol as carrier (18) . The product was partitioned between petroleum ether and methanol and the cholestanol was oxidized with perbenzoic acid and chromatographed as described (19) . The cholestanol so obtained was crystallized from acetonemethanol to constant specific activity.
Tissue studies in patients receiving labeled cholesterol. Postmortem tissue samples were obtained in three patients who died after receiving either 20 Ac of cholesterol-4-"C (Patient 10) or 500 and 1000 Ac cholesterol-7-3H (Patients 9 and 11, respectively). The tissue lipids were extracted with chloroform-methanol 2: 1 and the sterols were separated by TLC systems 1, 2, 3, and 4. The sterol content and radioactivity were measured as described above. With the liver and aorta of Patient 11, the cholestanol fraction from TLC system 3 was oxidized and recrystallized as described above and the cholestanol specific activity determined.
Purification of both 'H and "C-labeled cholesterol standards by TLC systems 1, 2, 3, and 4 revealed that 99.7%o of the radioactivity was recovered with cholesterol and the remaining 0.3%o with cholestanol.
In all of the analytical procedures, the results were corrected to 100% recovery. In representative arterial segments heat-killed in boiling H20 for 1 min before incubation with either "C-acetate or 'C-mevalonate, no radioactivity was recovered in any of the arterial sterol fractions.
RESULTS
A flow chart outlining the sequence of methods and the results obtained in a representative case (Patient 5) is illustrated in Fig. 1 .
Incorporation of "4C-acetate and 14C-mevalonate into total sterols. The incorporation of labeled acetate into the digitonin precipitable material (Table I) ranged from 34.7 to 3380 dpm/mg of cholesterol (5250 to 24,300 dpm/g of intima) and that of mevalonate (Table II) essentially to the unesterified or free sterols with (TLC system 2) ranged from 11.2 to 134 dpm/mg only a small portion in the sterol esters. The major of cholesterol for acetate and from 62.0 to 132 radioactivity measured in the sterol ester fraction dpm/mg of cholesterol for mevalonate. 53-77%o was distributed between the fatty acid portion of of the radioactivity isolated with the free sterols the sterol ester molecule, the squalene moiety (see (TLC system 1) was present in the C-27 sterol below), and an unidentified fraction which after group. The remaining radioactivity was recovered saponification and rechromatography had an R, from the TLC plate at the origin and at the edge value of 1.0. In the tissues incubated with acetate, of the solvent front. No radioactivity was recov-2.0-5.1% of the total lipid radioactivity was iso-ered in association with lanosterol or ergosterol lated with the free sterols, whereas with mevalo-when these materials were added as carriers nate, 5.2-11.8%of the lipid radioactivity was before chromatography. Further analysis of the recovered there.
C-27 sterol containing fraction by silicic acidThe incorporation of substrate into C-27 sterols super-cel column chromatography revealed all the mosterol, or lathosterol. Likewise with GLC analysis on SE-30 ( Fig. 3) , the total radioactivity was confined to the peak with retention time equal to cholesterol or cholestanol. The specific activities of the C-27 sterols, as measured by TLC system 2, column chromatography, and GLC on SE-30, were comparable. Incorporation of 14C-acetate and 14C-mevalonate into cholestanol and cholesterol. 51-71%o of the radioactivity in the C-27 sterols was isolated by TLC system 3 ( Fig. 4) in the fraction chromatographically identical to cholestanol, whereas the remaining 29-49%o was present in the cholesterol containing moiety (Table III) . No 7-dehydrocholesterol radioactivity was apparent. Essentially similar results were observed with GLC using the QF-1 column (Fig. 5) . The intimal content of cholesterol represented less than 1%o of total intimal sterols. The specific activity of cholestanol was greater than 100 times that of cholesterol, but could not be measured accurately in view of the small quantity of cholestanol present. The cholesterol and cholestanol containing fractions when further analyzed by TLC system 4 did not contain labeled lathosterol. The specific activity of cholestanol isolated by TLC system 3 decreased by 3% after oxidation and recrystallization procedures.
Using phosphate rather than lactate buffer in the incubation solution, or varying the incubation time from 3 to 12 hr did not influence the distribution of sterol radioactivity. In Patient 2, after 3 hr of incubation 65% of the sterol radioactivity was present as cholestanol and the remainder as cholesterol. In Patient 6, cholestanol represented 54%o of the total sterol radioactivity at 4 hr and 57%o at 12 hr with the remainder at both time periods as cholesterol.
Incorporation of acetate and mevalonate into squalene. The incorporation of acetate into the fraction chromatographically identical to squalene was 124 and 183 dpm/g of intima and that of mevalonate 284 dpm/g of intima (Table III) .
Dibromide purification of cholesterol. The cholesterol specific activity in extracts from TLC system 2 after bromination was 19-36%o of the sterol specific activity before bromination.
Tissue cholestanol and cholesterol radioactivity after labeled cholesterol administration. The aortic cholestanol radioactivity ranged from 0.4%o of total sterol radioactivity at 5 days to 4% at 104 days. At 20 days, the cholestanol radioactivity in the liver and kidney were 5% of that of total sterols, and at 104 days, the values for blood and liver were 3 and 4%o, respectively, of the total sterol radioactivity (Table IV) . The specific activity of cholestanol in the aorta of Patient 11
decreased by 2%o with oxidation and recrystallization, whereas that of the liver diminished by 6%o. DISCUSSION These studies indicate that the isolated human arterial intima has the capacity to incorporate acetate and mevalonate into cholestanol and cholesterol with the major incorporation into the cholestanol fraction. The latter finding was unexpected since cholestanol has not previously been reported to be the major sterol synthesized from these substrates. Although the present results might be due to experimental artifact created by the in vitro system, the general similarity of results in all arteries with both acetate and mevalonate as labeled substrate and with variations in the duration of incubation and in the composition of the incubation mixture argues against this.
The significance, if any, of arterial cholestanol synthesis in the pathogenesis of the atherosclerotic lesion remains to be determined. Experimental studies in birds have revealed that chronic cholestanol feeding can produce severe atherosclerosis which appears similar to that induced by choles-terol (20) . In man, cholestanol is present in small amounts in the arterial wall as well as in blood and other tissues and represents approximately 17o of the total sterol content of atherosclerotic plaques (21 ) .
The results also suggest that the human arterial intima, like that of the chicken, rabbit, calf, and rat (5-7), can synthesize cholesterol, but the quantitative role of this endogenous synthesis in the intimal accumulation of cholesterol is unclear. Previous investigations in rabbits and chickens have shown that most of the cholesterol deposited in the arterial wall is derived from the plasma (3, 22) . In man, the importance of plasma as the major source of arterial cholesterol has likewise been suggested by the similarity in composition of the fatty acids in the cholesterol esters of plasma and intima (23, 24) and by the comparable cholesterol specific activities in plasma and normal arterial intima after the administration of labeled cholesterol (4) . In atheromatous plaques where the cholesterol appears to exist in a compartment that is not freely exchangeable with plasma cholesterol (25) , local synthesis could conceivably represent an important source of arterial cholesterol. However, the absence of appreciable cholestanol accumulation in atherosclerotic lesions, even though it appeared to be the major sterol synthesized by the intima, would argue against this.
Small amounts of labeled cholestanol were present in all tissues of patients receiving labeled cholesterol which suggests that conversion of cholesterol to cholestanol had occurred. Although the administered cholesterol contained minute quantities of a labeled contaminant which was chromatographically identical to cholestanol, it is unlikely that this contaminant was the sole source of labeled tissue cholestanol since the ratio of labeled cholestanol to cholesterol in each tissue analyzed was greater than that present in the administered material. These results are consistent with those of Rosenfeld, Zumoff, and Hellman who recently demonstrated the transformation of cholesterol to cholestanol in man (26) . A similar capacity for converting cholesterol to cholestanol is also found in guinea pigs (27) but presumably not in rats (28) .
Labeled cholestanol represented only 0.4% of the cholesterol radioactivity in the intima 5 days after labeled cholesterol administration. At 20 days, however, the intimal cholestanol radioactivity had risen to 2%o of that of cholesterol and the ratio of labeled cholestanol/cholesterol in the intima was approximately 40%o of that in the liver and kidney. Finally, by 104 days, the labeled cholestanol/cholesterol ratios in the blood, liver, and intima were essentially comparable. These findings suggest that the exchange of cholestanol between blood and tissues may be similar to that of cholesterol and, perhaps, of desmosterol, as well (4, 29 
